Data / Form D filings / Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc.: Form D filings
Amarantus Bioscience Holdings, Inc., a pharmaceuticals company in San Francisco, CA, filed 4 Form D notices with the SEC between 2013 and 2018. The latest, on March 12, 2018, reports $300,000 sold of a $1.5 million offering to 1 investor.
Find out what Amarantus Bioscience Holdings, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 953 INDIANA STREET, San Francisco, CA, 94104
- Phone
- (917) 686-5317
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1424812
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 12, 2018 | New notice | $1,500,000 | $300,000 | $1,200,000 | 1 | Feb 26, 2018 | sec.gov |
| Nov 17, 2014 | New notice | $3,000,000 | $3,000,000 | $0 | 1 | Nov 7, 2014 | sec.gov |
| Sep 13, 2013 | New notice | $5,000,000 | $1,390,000 | $3,610,000 | 5 | Sep 6, 2013 | sec.gov |
| Aug 28, 2013 | New notice | $1,299,327 | $1,299,327 | $0 | 1 | Aug 19, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gerald Commissiong | Executive Officer, Director | |
| Donald Huffman | Director | |
| John Commissiong | Executive Officer, Director | |
| Robert Harris | Director | |
| Steven Spence | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Mar 12, 2018 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Amarantus Bioscience Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.